Isoprostanes: Novel bioactive products of lipid peroxidation

Free Radical Research

Volumn 38, Issue 2, 2004, Pages 105-122

  Basu, Samar ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Diet; Diseases; Free radical; Isoprostanes; Lipid peroxidation; Oxidative stress

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ALPHA TOCOPHEROL; ALPHA TOCOPHEROL SUCCINATE; ANTIOXIDANT; APOLIPOPROTEIN E; ASCORBIC ACID; BIOCHEMICAL MARKER; BIOLOGICAL MARKER; CAROTENE; DOCOSAHEXAENOIC ACID; FISH OIL; FREE RADICAL; ICOSAPENTAENOIC ACID; INTERLEUKIN 8; ISOPROSTANE; ISOPROSTANE DERIVATIVE; LINOLEIC ACID; OLEIC ACID; OLIVE OIL; POLYUNSATURATED FATTY ACID; PROPOFOL; PROSTAGLANDIN; PROTEIN KINASE C; RETINOL; RETINOL PALMITATE; ROFECOXIB; THROMBOXANE RECEPTOR STIMULATING AGENT; UNINDEXED DRUG; VACCENIC ACID; VASOCONSTRICTOR AGENT;

ATHEROSCLEROSIS; BIOSYNTHESIS; CARDIOVASCULAR DISEASE; CATALYSIS; CLINICAL TRIAL; DEGENERATIVE DISEASE; DIABETES MELLITUS; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DRUG ACTIVITY; DRUG HALF LIFE; DRUG POTENCY; DRUG STRUCTURE; ESTERIFICATION; HUMAN; INFLAMMATORY DISEASE; KIDNEY BLOOD VESSEL; LIPID PEROXIDATION; LUNG BLOOD VESSEL; NONHUMAN; PREGNANCY; PROSTAGLANDIN BLOOD LEVEL; PROSTAGLANDIN METABOLISM; RELIABILITY; REPERFUSION INJURY; REVIEW; TISSUE DISTRIBUTION; URINE LEVEL; VASOCONSTRICTION;

ANIMALS; ANTIOXIDANTS; DIETARY SUPPLEMENTS; DRUG EVALUATION; F2-ISOPROSTANES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; IMMUNOASSAY; LIPID PEROXIDATION; MODELS, ANIMAL; OXIDATIVE STRESS; PROSTAGLANDINS; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2;

ANIMALIA;

EID: 0842302396     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715760310001646895     Document Type: Review

References (188)

1. 1", Recl. Trav. Chim. Pays-Bas. 86, 1237-1245.
2. Porter, N.A. and Funk, M.O. (1975) "Peroxy radical cyclization as a model for prostaglandin synthesis", J. Org. Chem. 40, 3614-3615.
3. Mihelich, E.D. (1980) "Structure and stereochemistry of novel endoperoxide isolated from the sensitized photooxidation of methyl linoleate. Implication for prostaglandin biosynthesis", J. Am. Chem. Soc. 102, 7141-7143.
4. Morrow, J.D., Hill, K.E., Burk, R.F., Nammour, T.M., Badr, K.F. and Roberts, L.J., II (1990) "A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalysed mechanism", Proc. Natl Acad. Sci. USA 87, 9383-9387.
5. Morrow, J.D., Harris, T.M. and Roberts, L.J. II (1990) "Non-cyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramification for measurement of eicosanoids", Anal. Biochem. 184, 1-10.
6. 2-isoprostanes) are formed in situ on phosphlipids", Proc. Natl Acad. Sci. USA 89, 10721-10725.
7. -isoprostanes as an index of oxidative stress in vivo", Free Radic. Biol. Med. 28, 505-513.
8. O'Connor, D.E., Mihelich, E.D. and Coleman, M.C. (1984) "Stereochemical course of the autooxidised cyclization of the lipid hydroperoxides to prostaglandin-like bicyclo endoperoxides", J. Am. Chem. Soc. 106, 3577-3584.
9. Morrow, J.D. (2000) "The isoprostanes: their quantification as an index of oxidant stress status in vivo", Drug Metab. Rev. 32, 377-385.
10. 2α, is formed in vivo", Biochim. Biophys. Acta 1210, 244-248.
11. Roberts, L.J., II and Morrow, J.D. (2002) "Products of isoprostane pathway: Unique bioactive compounds and markers of lipid peroxidation", Cell. Mol. Life Sci. 59, 808-820.
12. Brame, C.J., Salomon, R.G., Morrow, J.D. and Roberts, L.J., II (1999) "Identification of extreamly reactive γ-ketoaldehydes (isolevuglandins) as products of isoprostane pathway and characterization of their lysyl protein adducts", J. Biol. Chem. 274, 13139-13146.
13. 3-isoprostanes during peroxidation of eicosapentaenoic acid", Biochem. Biophys. Res. Commun. 236, 467-472.
14. 4-isoprostanes during peroxidation of eicosapentaenoic acid. A novel class of prostanoids formed during peroxidation of docosahexaenoic acid (DHA)", Biochem. Biophys. Res. Commun. 242, 338-344.
15. Morrow, J.D., Minton, T.A., Mukundan, C.R., Campbell, M.D., Zackert, W.E., Daniel, V.C., Badr, K.F., Blair, I.A. and Roberts, L.J., II (1994) "Free radical-induced generation of isoprostanes in vivo", J. Biol. Chem. 269, 4317-4326.
16. 2α: an index for oxidative injury via free radical catalysed lipid peroxidation", Prostaglandins Leukot. Essent. Fatty Acids 58, 319-325.
17. 2α: an index for inflammation via cyclooxygenase catalysed lipid peroxidation", Prostaglandins Leukot. Essent. Fatty Acids 58, 347-352.
18. 2α in humans", J. Biol. Chem. 271, 20617-20620.
19. 2α", J. Biol. Chem. 274, 1313-1319.
20. 2α", FEBS Lett. 428, 32-36.
21. Hamberg, M., Israelsson, U. and Samuelsson, B. (1971) "Metabolism of prostaglandins", Ann. NY Acad. Sci. 180, 138-163.
22. Samuelsson, B., Granström, E., Gréen, K., Hamberg, M. and Hammarström, S. (1975) "Prostaglandins", Ann. Rev. Biochem. 44, 669-695.
23. 2α in the rabbit", Prostaglandins Leukot. Essent. Fatty Acids 57, 267.
24. 13 reductase in tissues of the swine", Acta Physiol. Scand. 81, 391-404.
25. 13-reductase in the porcine cornea", Acta Chem. Scand. 46, 108-110.
26. 13-Reductase dependent metabolism of prostaglandins in the mammalian brain and eye", Prostaglandins Leukot. Essent. Fatty Acids 57, 305-310.
27. Halliwell, B. (1994) "Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?", Lancet 10, 721-724.
28. Halliwell, B. and Gutteridge, J.M.C. (1999) Free Radical Biology and Medicin, 3rd Ed. (Oxford University Press, New York).
29. Halliwell, B. and Grootveld, M. (1987) "The measurement of free radical reactions in humans. Some thoughts for human experimentation", FEBS Lett. 213, 9-14.
30. Cracowski, J.-L., Durand, T. and Bessard, G. (2002) "Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical applications", Trends Pharmacol. Sci. 135, 360-366.
31. Lawson, J.A., Rokach, J. and FitzGerald, G.A. (1999) "Isoprostanes: formation analysis and use of indicies of lipid peroxidation in vivo", J. Biol. Chem. 27, 24441-24444.
32. 4 hepatotoxicity", J. Clin. Investig. 90, 2502-2507.
33. Basu, S. (1999) "Oxidative injury induced cyclooxygenase activation in experimental hepatotoxicity", Biochem. Biophys. Res. Commun. 254, 764-767.
34. Södergren, E., Cederberg, J., Vessby, B. and Basu, S. (2001) "Vitamin E reduces lipid peroxidation in experimental hepatotoxicity in rats", Eur. J. Nutr. 40, 10-16.
35. Richelle, M., Turini, M.E., Guidoux, R., Tavazzi, I., Metairon, S. and Fay, L.B. (1999) "Urinary isoprostane excretion is not confounded by the lipid content of diet", FEBS Lett. 459, 259-262.
36. 2-isoprostanes as index of lipid peroxidation does not appear to be confounded by diet", Free Radic. Res. 33, 115-117.
37. 2α in rats", J. Nutr. 130, 10-14.
38. Ghosal, A.K. and Recknagel, R.O. (1965) "Positive evidence of acceleration of lipid peroxidation in rat liver by carbon tetrachloride: in vitro experiments", Life Sci. 4, 1521-1530.
39. 4 in vitro and in vivo on lipid peroxidation of rat liver homogenates and subcellular fractions", Enzymologia 29, 185-204.
40. Glende, E.A., Jr., Hruszkewycz, A.M. and Recknagel, R.O. (1976) "Critical role of lipid peroxidation in carbon tetrachloride-induced loss of aminopyrine demethylase, cytochrome P-450 and glucose-6-phosphatase", Biochem. Pharmacol. 25, 2163-2170.
41. Ingall, A., Lott, K.A. and Slater, T.F. (1978) "Metabolic activation of carbon tetrachloride to a free-radical product: studies using a spin trap", Biochem. Soc. Trans. 6, 962-978.
42. Basu, S. (2003) "Carbon tetrachloride induced lipid peroxidation: eicosanoid formation and its regulation by antioxidants", Toxicology 189, 113-127.
43. 2-isoprostanes after hydrolysis of lipids in tissues", Prostaglandins Leukot. Essent. Fatty Acids 63, 149-152.
44. Halliwell, B. (2000) "Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward", Cardiovasc. Res. 18, 410-418.
45. 2α excretion in man", J. Pharmacol. Exp. Ther. 275, 94-100.
46. 2α-I: an index of lipid peroxidation in humans", Proc. Natl Acad. Sci. USA 95, 3449-3454.
47. 2α excretion rate and diurnal variation in urine in normal subjects", Prostaglandins Leukot. Essent. Fatty Acids 61, 203-205.
48. Basu, S., Smedman, A. and Vessby, B. (2000) "Conjugated linoleic acid induces lipid peroxidation in humans", FEBS Lett. 468, 33-36.
49. 2α metabolite excretion rate and day to day variation in healthy humans", Prostaglandins Leukot. Essent. Fatty Acids 65, 99-102.
50. Mutschler, D.K., Eriksson, M.B., Wikström, B.G., Lind, L., Larsson, A., Bergren-Kiiski, R., Lagrange, A., Nordgren, A. and Basu, S. (2003) "Microdialysis-evaluated myocardial COX-mediated inflammation and early circulatory depression in porcine endotoxemia", Crit. Care Med. 31, 1780-1785.
51. 2 receptors", J. Clin. Investig. 90, 131-141.
52. 2α in rabbit lung in situ", Am. J. Physiol. 263, H660-H663.
53. 2A in anaesthesized guinea pigs", Pharmacol. Res. 37, 75-80.
54. Wagner, R.S., Weare, C., Jin, N., Mohler, E.R. and Rhoades, R.A. (1997) "Characterization of signal transduction events stimulated by 8-epi-prostaglandin (PG) F2 alpha in rat aortic rings", Prostaglandins 54, 581-599.
55. Lahaie, I., Hardy, P., Hou, X., Hassessian, H., Asselin, P., Lachapelle, P., Almazan, G., Varma, D.R., Morrow, J.D., Roberts,L.J., II and Chemtob, S. (1998) "A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2 alpha on retinal vessels", Am. J. Physiol. 274, R1406-R1416.
56. Hoffman, S.W., Moore, S. and Ellis, E.F. (1997) "Isoprostanes: free radical-generated PGs with constrictor effects on cerebral arteries", Stroke 28, 844-849.
57. 2α levels in healthy subjects", J. Vasc. Res. 36, 486-491.
58. 2, on the platelet thromboxane/endoperoxide receptor in humans and rats: Additional evidence for the existence of a unique isoprostane receptor", Prostaglandins 48, 247-256.
59. 2α in the rabbit", Free Radic. Res. Abs. 37, 79.
60. Roberts, L.J., II, Montine, T.J., Markesbery, W.R., Tapper, A.R., Hardy, P., Chemtob, S., Dettbarn, W.D. and Morrow, J.D. (1998) "Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid", J. Biol. Chem. 273, 13605-13612.
61. Meagher, E.A., Barry, O.P., Burke, A., Lucey, M.R., Lawson, J.A., Rokach, J. and FitzGerald, G.A. (1999) "Alcohol induced generation of lipid peroxidation products in humans", J. Clin. Investig. 104, 805-813.
62. Aleynik, S.I., Leo, M.A., Ma, X., Aleynik, M.K. and Lieber, C.S. (1997) "Polyenylphosphatidyl choline prevents carbon tetrachloride-induced lipid peroxidation while it attenuates liver fibrosis", J. Hepatol. 27, 554-561.
63. 2-isoprostanes) in smokers", N. Engl. J. Med. 332, 1198-1203.
64. Reilly, M., Delanty, N., Lawson, J.A. and FitzGerald, G.A. (1996) "Modulation of oxidant stress in vivo in chronic cigarette smokers", Circulation 94, 19-25.
65. Sinzinger, H. (2000) "Eicosanoid production and lymphatic responsiveness in human cigarette smokers compared to non-smokers", Lymphology 33, 24-31.
66. Montuschi, P., Collins, J.V., Ciabattoni, G., Lazzeri, N., Corradi, M., Kharitonov, S.A. and Barnes, P.J. (2000) "Exhaled 8-isoprostane as in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers", Am. J. Respir. Crit. Care Med. 162, 1175-1177.
67. Oguogho, A., Lupattelli, G., Palumbo, B. and Sinzinger, H. (2000) "Isoprostanes quickly normalize after quitting cigarette smoking", Vasa 29, 103-105.
68. 2α", Prostaglandins Leukot. Essent. Fatty Acids 64, 307-310.
69. 2α metabolite levels in man with migraine", Clin. Sci. (London) 102, 39-43.
70. Ide, T., Tsutsui, H., Ohashi, N., Hayashidani, S., Suematsu, N., Tsuchihashi, M., Tamai, H. and Takeshita, A. (2002) "Greater oxidative stress in healthy young men compared with premenopausal women", Arterioscler. Thromb. Vasc. Biol. 22, 438-442.
71. Basu, S., Michaelsson, K., Olofsson, H., Johansson, S. and Melhus, H. (2001) "Association between oxidative stress and bone mineral density", Biochem. Biophys. Res. Commun. 288, 275-279.
72. 2α in different rheumatic diseases", Ann. Rheum. Dis. 60, 627-631.
73. Cracowski, J.L., Marpeau, C., Carpentier, P.H., Imbert, B., Hunt, M., Stanke-Labesque, F. and Bessard, G. (2001) "Enhansed in vivo lipid peroxidation in scleroderma spectrum disorders", Arthritis Rheum. 44, 1143-1148.
74. 2-isoprostanes in systeirtic sclerosis but not in primary Raynaud's phenomenon. Effect of a cold exposure", Arthritis Rheum. 46, 1319-1323.
75. Stein, C.M., Tanner, S.B., Awad, J.A., Roberts, L.J., II and Morrow, J.D. (1996) "Evidence of free radical mediated injury (isoprostane overproduction) in scleroderma", Arthritis Rheum. 39, 1146-1150.
76. 2-isoprostane concentration in probable AD", Neurology 52, 562-565.
77. 2-isoprostanes are elevated in Huntington's disease", Neurology 52, 1104-1105.
78. Montine, T.J., Markesbery, W.R., Zackert, W., Sanchez, S.C., Roberts, L.J., II and Morrow, J.D. (1999) "The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with the density of the neuritic plaques and neorofibrillary tangles or with APOE genotype in Alzheimer's disease patients", Am. J. Pathol. 155, 863-868.
79. 2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo", FASEB J. 12, 1777-1783.
80. 2α, an in vivo marker of oxidative stress, are not effected by aging or Alzheimer's disease", Free Radic. Biol. Med. 27, 463-469.
81. 2-isoprostanes among patients with Huntington's or Alzheimer's disease", Ann. Neurol. 48, 950.
82. Monga, M., Dunn, K. and Rajasekaran, M. (2001) "Characterization of ultrastructural and metabolic abnormalities in semen from men with spinal cord injury", J. Spinal Cord Med. 24, 41-46.
83. Montuschi, P., Corradi, M., Ciabattoni, G., Nightingale, J., Kharitonov, S.A. and Barnes, P.J. (1999) "Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients", Am. J. Respir. Crit. Care Med. 160, 216-220.
84. Wood, L.G., Fitzgerald, D.A., Gibson, P.G., Cooper, D.M. and Garg, M.L. (2000) "Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma", Lipids 35, 967-974.
85. Montuschi, P., Ciabattoni, G., Paredi, P., Pantelidis, P., du Bois, R.M., Kharitonov, S.A. and Barnes, P.J. (1998) "8-isoprostane as biomarker of oxidative stress in interstial lung diseases", Am. J. Respir. Crit. Care Med. 158, 1524-1527.
86. 2-isoprostane in cystic fibrosis", Lipids 34, 551-572.
87. Ciabattoni, G., Davi, G., Collura, M., Iapichino, L., Pardo, F., Ganci, A., Romagnoli, R., Maclouf, J. and Patrono, C. (2000) "In vivo lipid peroxidation and platelet activation in cystic fibrosis", Am. J. Respir. Crit. Care Med. 162, 1195-1201.
88. Montuschi, P., Kharitonov, S.A., Ciabattoni, G., Corradi, M., van Rensen, L., Geddes, D.M., Hodson, M.E. and Barnes, P.J. (2000) "Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis", Thorax 55, 205-209.
89. Cracowski, J.L., Cracowski, C., Bessard, G., Pepin, J.L., Bessard, J., Schwebel, C., Stanke-Labesque, F. and Pison, C. (2001) "Increased lipid peroxidation in patients with pulmonary hypertension", Am. J. Crit. Care Med. 164, 1248-1252.
90. 2-isoprostanes in acute chest syndrome of sickle cell disease as a marker of oxidative stress", Am J. Respir. Crit. Care Med. 164, 1248-1252.
91. Barden, A., Beilin, L.J., Ritchie, J., Croft, K.D., Walters, B.N. and Michael, C.A. (1996) "Plasma and urinary 8-isoprostane as an indicator of lipid peroxidation in preeclampsia and normal pregnancy", Clin. Sci. (Lond.) 91, 711-718.
92. Walsh, S.W., Vaughan, J.E., Wang, Y. and Roberts, L.J., II (2000) "Placental isoprostane isoprostanes significantly increased in preeclampsia", FASEB J. 14, 1289-1296.
93. Morris, J.M., Gopaul, N.K., Endresen, M.J., Knight, M. Linton, E.A., Dhir, S., Anggard, E.E. and Redman, C.W. (1998) "Circulating markers of oxidative stress raised in normal pregnancy and pre-eclampsia", Br. J. Obstet. Gynaecol. 105, 1195-1199.
94. Regan, C.L., Levine, R.J., Baird, D.D., Ewell, M.G., Martz, K.L., Sibai, B.M., Rokach, J., Lawson, J.A. and Fitzgerald, G.A. (2001) "No evidence for lipid peroxidation in severe preeclampsia", Am. J. Obstet. Gynaecol. 185, 572-578.
95. Basu, S., Hayashi, M., Nitta, R., Kobayashi, K., Takeda, K. and Ishihara, O. (2002) "Levels of lipid peroxidation products and antioxidants in preeclampsia, normal pregnancy and nonpregnancy", Free Radic. Biol. Med. 33(2), 409.
96. 2-isoprostanes in human atherosclerotic lesions", J. Clin. Investig. 100, 2028-2034.
97. 2-isoprostanes are present in increased amounts in human atherosclerotic lesions", Arterioscler. Thromb. Vasc. Biol. 17, 2975-2981.
98. 2α, is accumulated in coronary arteries isolated from patients with coronary heart disease", Cardiovasc. Res. 43, 492-499.
99. Cipollone, F., Ciabattoni, G., Patrignani, P., Pasquale, M., Di Gregorio, D., Bucciarelli, T., Davi, G., Cuccurullo, F. and Patrono, C. (2000) "Oxidant stress and aspirin insensitive thromboxane biosynthesis in severe unstable angina", Circulation 102, 1007-10013.
100. 2α generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo", Circulation 95, 2492-2499.
101. Ulus, A.T., Aksoyek, A., Ozkan, M., Katircioglu, S.F. and Basu, S. (2003) "Cardiopulmonary bypass as a cause of free radical-induced oxidative stress and enhanced blood-borne isoprostanes in humans", Free Radic. Biol. Med. 34, 911-917.
102. 2α in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans", Circulation 96, 3314-3320.
103. 2-isoprostane formation: evidence for in vivo oxidative stress during PTCA", J. Am. Coll. Cardiol. 37, 76-80.
104. 2α in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure", Circulation 97, 1536-1539.
105. 2-isoprostanes in patients with severe heart failure", Heart 84, 439-440.
106. Gopaul, N.K., Anggard, E.E., Mallet, A.I., Betteridge, D.J., Wolff, S.P. and Nourooz-Zadeh, J. (1995) "Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus", FEBS Lett. 17, 225-229.
107. 2α and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation", Circulation 99, 224-229.
108. Murai, Y., Hishimuna, T., Suzuki, N., Satoh, J., Toyota, T. and Mizugaki, M. (2000) "Determination of 8-epi prostaglandin F (2alpha) using liquid chromatography-tandem mass spectrometry: increased excretion in diabetics", Prostaglandins Other Lipid Mediat. 62, 173-181.
109. Helmersson, J., Vessby, B. and Basu, S. (2002) "Inflammation and oxidative injury in elderly men with type 2 diabetes", Free Radic. Biol. Med. 33(2), S344.
110. Vessby, J., Basu, S., Mohsen, R., Berne, C. and Vessby, B. (2002) "Oxidative stress and antioxidant status in Type 1 diabetes mellitus", J. Intern. Med. 251, 69-76.
111. O'Byrne, S., Forte, P., Roberts, L.J., II, Morrow, J.D., Johnston, A., Änggård, E., Leslie, R.D. and Benjamin, N. (2000) "Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion", Diabetes 49, 857-862.
112. Nanji, A.A., Khwaja, S., Tahan, S.R. and Sadrzadeh, S.M. (1994) "Plasma levels of a novel noncyclooxygenase-derived prostanoid (8-isoprostane) correlate with severity of liver injury in experimental alcoholic liver disease", J. Pharmacol. Exp. Ther. 269, 1280-1285.
113. McCord, J.M. (1985) "Oxygen-derived free radicals in post ischemic tissue injury", N. Engl. J. Med. 312, 159-163.
114. McCord, J.M. (1987) "Oxygen-derived radicals: a link between reperfusion injury and inflammation", Fed. Proc. 46, 2402-2406.
115. Basu, S., Hellberg, A., Ulus, A.T., Westman, J. and Karacagil, S. (2001) "Biomarkers of free radical injury during spinal cord ischemia", FEBS Lett. 508, 36-38.
116. Basu, S., Nozari, A., Liu, X.L., Rubertsson, S. and Wiklund, L. (2000) "Development of a novel biomarker of free radical damage in reperfusion injury after cardiac arrest", FEBS Lett. 470, 1-6.
117. Basu, S., Liu, X., Nozari, A., Rubertsson, S., Miclescu, A. and Wiklund, L. (2003) "Evidence for time-dependent maximum increase of free radical damage and eicosanoid formation in the brain as related to duration of cardiac arrest and cardiopulmonary resuscitation", Free Radic. Res. 37, 251-256.
118. Liu, X.L., Nozari, A., Basu, S., Ronquist, G., Rubertsson, S. and Wiklund, L. (2002) "Neurological outcome after experimental cardiopulmonary resuscitation: a result of delayed and potentially treatable neuronal injury?", Acta Anaesthesiol. Scand. 46, 537-546.
119. Liu, X.L., Wiklund, L., Nozari, A., Rubertsson, S. and Basu, S. (2003) "Differences in cerebral reperfusion and oxidative injury after cardiac arrest in pigs", Acta Anaesthesiol. Scand. 47, 958-967.
120. Basu, S. and Eriksson, M. (1998) "Oxidative injury and survival during endotoxemia", FEBS Lett. 438, 159-160.
121. Basu, S. and Eriksson, M. (2000) "Lipid peroxidation induced by an early inflammatory response in endotoxemia", Acta Anaesthesiol. Scand. 44, 17-23.
122. Basu, S. and Eriksson, M. (2000) "Vitamin E in relation to lipid peroxidation in experimental septic shock", Prostaglandins Leukot. Essent. Fatty Acids 62, 195-199.
123. Scholz, H., Yndestad, Damås, T., Tonstad, S., Aukrust, P. and Halvorsen, P. (2003) "8-Isoprostane increases expression of interleukin-8 in human macrophages through activation of mitogen-activated protein kinases", Cardiovasc. Res. 59, 945-954.
124. Sentman, M.L., Brännstrom, T., Westerlund, S., Laukkanen, M.O., Yla-Herttuala, S., Basu, S. and Marklund, S.L. (2001) "Extracellular superoxide dismutase deficiency and atherosclerosis in mice", Arterioscler. Thromb. Vasc. Biol. 21, 1477-1482.
125. Cederberg, J., Basu, S. and Eriksson, U.J. (2001) "Increased rate of lipid peroxidation and carbonylation in experimental diabetic pregnancy", Diabetologia 44, 766-774.
126. 2-isoprostanes", J. Nutr. 124, 810-816.
127. Burk, R.F., Hill, K.E., Awad, J.A., Morrow, J.D., Kato, T., Cockell, K.A. and Lyons, P.R. (1995) "Pathogenesis of diquat-induced liver liver necrosis in selenium-deficient rats: assessment of the roles of lipid peroxidation and seleno protein", Hepatology 21, 561-569.
128. 2-isoprostane generation in isolated ferret lung after oxidant injury or ventilated ischemia", Free Radic. Biol. Med. 25, 703-711.
129. Freese, R., Basu, S., Heitanen, E., Nair, J., Burtsch, H. and Mutanen, M. (1999) "Green tea extract decreases plasma malondialdehyde concentration but does not affect other indicators of oxidative stress, nitric oxide production, or hemostatic factors during a high-linoleic acid diet in healthy females", Eur. J. Nutr. 38, 149-157.
130. Dragstedt, L.O., Pedersen, A., Hermetter, A., Basu, S., Hansen, S., Ravn-Haren, G., Kall, M., Breinholt, V., Castenmiller, J., Stagsted, J., Jakobsen, J., Skibsted, L.H., Loft, S.E. and the late Sandström, B. (2003) "The 6-a-day study: effects of fruits and vegetables on markers of oxidative stress and defence in healthy non-smokers", Am. J. Clin. Nutr., (Final submission).
131. Freese, R., Alfthan, G., Jauhiainen, M., Basu, S., Erlund, I., Salminen, I., Aro, A. and Mutanen, M. (2002) "High intakes of vegetables, berries and apple combined with high intake of linoleic acid or oleic acid only slightly effect markers of lipid peroxidation or lipoprotein metabolism in healthy subjects", Am. J. Clin. Nutr. 76, 950-960.
132. Visioli, F., Caruso, D., Galli, C., Viappiani, S., Galli, G. and Sala, A. (2000) "Olive oil rich in natural catecholic phenols decrease isoprostane excretion in humans", Biochem. Biophys. Res. Commun. 278, 797-799.
133. 2-isoprostanes", Am. J. Clin. Nutr. 72, 714-722.
134. 2-isoprostane excretion in non-insulin-dependent diabetic patients", Metabolism 48, 1402-1408.
135. Turpeinen, A.M., Basu, S. and Mutanen, M. (1998) "A high linoleic acid diet increases oxidative stress in vivo and affects nitric oxide metabolism in humans", Prostaglandins Leukot. Essent. Fatty Acids 59, 229-233.
136. Basu, S., Risérus, U., Turpeinen, A. and Vessby, B. (2000) "Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity", Clin. Sci. (Lond.) 99, 511-516.
137. Risérus, U., Basu, S., Jovinge, S., Fredrikson, G.N., Arnlov, J. and Vessby, B. (2002) "Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein. A potential link to fatty acid-induced insulin resistance", Circulation 106, 1925-1929.
138. Smedman, A., Vessby, B. and Basu, S. (2004) "Isomer specific effects of conjugated linoleic acid on lipid peroxidation in humans. Regulation by Alpha Tocopherol and Cyclooxygenase-2 inhibitor", Clin. Sci. (Lond.) 106, 67-73.
139. Turpeinen, A.M., Mutanen, M., Salminen, I., Basu, S., Palmquist, D.L. and Griinary, M.J. (2002) "Bioconversion of vaccenic acid to conjugated linoleic acid in humans", Am. J. Clin. Nutr. 76, 504-510.
140. Meagher, E.A., Barry, O.P., Lawson, J.A., Rokach, J. and FitzGerald, G.A. (2001) "Effects of vitamin E on lipid peroxidation in healthy persons", J. Am. Med. Assoc. 285, 1178-1182.
141. Levine, M., Wang, Y., Padayatty, S.J. and Morrow, J. (2001) "A new recommended dietary allowance of vitamin C for healthy young women", Proc. Natl Acad. Sci. USA 98, 9842-9846.
142. Patrignani, P., Panara, M.R., Tacconelli, S., Seta, F., Bucciarelli, T., Ciabattoni, G., Alessandrini, P., Mezzetti, A., Santini, G., Sciulli, M.G., Cipollone, F., Davi, G., Gallina, P., Bon, G.B. and Patrono, C. (2000) "Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers", Circulation 102, 539-545.
143. Weinberg, R.B., VanderWerken, B.S., Anderson, R.A., Stegner, J.E. and Thomas, J. (2001) "Pro-oxidant effect of vitamin E in cigarette smokers consuming a high polyunsaturated fat diet", Arterioscler. Thromb. Vasc. Biol. 21, 1029-1033.
144. Roberts, L.J., II, Oates, J.A., Fazio, S., Gross, M.D., Linton, M.F. and Morrow, J.D. (2002) "A-Tocopherol supplementation reduces F2-isoprostane concentrations in hypercholessterolemic humans only at doses of 800 IU or higher", Free Radic. Biol. Med. 33(2), 412.
145. 2α is increased in hypercholesteromia", Arterioscler. Thromb. Vasc. Biol. 17, 3230-3235.
146. Davi, G., Di Minno, G., Coppola, A., Andria, G., Cerbone, A.M., Madonna, P., Tufano, A., Falco, A., Marchesani, P., Ciabattoni, G. and Patrono, C. (2001) "Oxidative stress and platelet activation in homozygous homocystinuria", Circulation 104, 1124-1128.
147. Pratico, D., Iuliano, L., Basili, S., Ferro, D., Camastra, C., Cordova, C., FitzGerald, G.A. and Voli, F. (1998) "Enhansed lipid peroxidation in hepatic cirrhosis", J. Investig. Med. 46, 51-57.
148. Pratico, D., Tangirala, R.K., Rader, D.J., Rokach, J. and FitzGerald, G.A. (1998) "Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice", Nat. Med. 4, 1189-1192.
149. Aleynik, S.I., Leo, M.A., Aleynik, M.K. and Lieber, C.S. (1998) "Increased circulating products of lipid peroxidation in patients with alcoholic liver disease", Alcohol. Clin. Exp. Res. 22, 192-196.
150. Basu, S. and Eriksson, M. (2000) "Retinol palmitate counteracts oxidative injury during experimental septic shock", Annals Acad. Sci. (Singapore) 30, 265-269.
151. Basu, S., Mutschler, D.K., Larsson, A.O., Kiiski, R., Nordgren, A. and Eriksson, M.B. (2001) "Propofol (Diprivan-EDTA) counteracts oxidative injury and deterioration of the arterial oxygen tension during experimental septic shock", Resuscitation 50, 341-348.
152. Eriksson, M., Basu, S., Larsson, A., Mattsson, C., Eriksson, O., Kiiski, R. and Nordgren, A. (2000) "Effects of melagatran, a novel direct thrombin inhibitor, during experimental septic shock", Expert Opin. of Investig. Drugs 9, 1129-1137.
153. 2α-VI in Alzheimer's disease: correlation of a non-invasive index of lipid peroxidation with disease severity", Ann. Neurol. 48, 809-812.
154. Raal, F.J., Pilcher, G.J., Waisberg, R., Philani Buthelezi, E., Veller, M.G. and Joffe, B.I. (1999) "Low-density lipoprotein cholesterol bulk is the pivotal determinant of atherosclerosis in familial hypercholesterolemia", Am. J. Cardiol. 83, 1330-1333.
155. Berg, K., Wiseth, R., Basu, S., Skarra, S., Bjerve, K., Gunnes, S., Brurok, H. and Jynge, P. (2003) "Oxidative stress and myocardial damage during elective percutaneous coronary interventions and coronary angiography. A comparison of blood-borne isoprostane and troponin release", Free Radic. Biol. Med. Abs. 35, S130.
156. Reilly, M.P., Pratico, D., Delanty, N., DiMinno, G., Tremoli, E., Rader, D., Kapoor, S., Rokach, J., Lawson, J. and FitzGerald, G.A. (1998) "Increased formation of distinct F2 isoprostanes in hypercholesterolemia", Circulation 98, 2822-2828.
157. Cracowski, J.L., Ploin, D., Bessard, J., Baguet, J.P., Stanke-Labesque, F., Mallion, J.M., Bost, M. and Bessard, G. (2001) "Formation of isoprostanes in children with type IIa hypercholesterolemia", J. Cardiovasc. Pharmacol. 38, 13381-13386.
158. Carpenter, C.T., Price, P.V. and Christman, B.W. (1998) "Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS", Chest 114, 1653-1659.
159. Montuschi, P., Collins, J.V., Ciabattoni, G., Lazzeri, N., Corradi, M., Kharitonov, S.A. and Barnes, P.J. (2000) "Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers", Am. J. Respir. Crit. Care Med. 162, 1175-1177.
160. Pratico, D., Basili, S., Vieri, M., Cordova, C., Violi, F. and Fitzgerald, G.A. (1998) "Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress", Am. J. Respir. Crit. Care Med. 158, 1709-1714.
161. Baraldi, E., Ghiro, L., Piovan, V., Carraro, S., Ciabattoni, G., Barnes, P.J. and Montuschi, P. (2003) "Increased exhaled 8-isoprostane in childhood asthma", Chest 124, 25-31.
162. Davi, G., Chiarelli, F., Santilli, F., Pomilio, M., Vigneri, S., Falco, A., Basili, S., Ciabattoni, G. and Patrono, C. (2003) "Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration", Circulation 107, 3199-3203.
163. Hoeldtke, R.D., Bryner, K.D., McNeill, D.R., Warehime, S.S., Van Dyke, K. and Hobbs, G. (2003) "Oxidative stress and insulin requirements in patients with recent-onset type 1 diabetes", J. Clin. Endocrinol. Metab. 88, 1624-1628.
164. 2α levels in normotensive and preeclamptic pregnancies", Am. J. Obstet. Gynecol. 183, 874-877.
165. Barden, A., Ritchie, J., Walters, B., Michael, C., Rivera, J., Mori, T., Croft, K. and Beilin, L. (2003) "Study of plasma factors associated with neutrophil activation and lipid peroxidation in preeclampsia", Hypertension 38, 803-808.
166. Montine, T.J., Quinn, J.F., Milatovic, D., Silbert, L.C., Dang, T., Sanchez, S., Terry, E., Roberts, II, L.J., Kaye, J.A. and Morrow, J.D. (2003) "Peripheral F2-isoprostanes and F4-neuro-prostanes are not increased in Alzheimer's disease", Ann. Neurol. 52, 175-179.
167. Fessel, J.P., Hulette, C., Powell, S., Roberts, L.J, II and Zhang, J. (2003) "Isofurans, but not F2-isoprostanes, are increased in the substantia nigra of patients with Parkinson's disease and with dementia with Lewy body disease", J. Neurochem. 85, 645-650.
168. 2α levels in the urine of patients with prostate cancer prior to and during radiotherapy", J. Radiat. Oncol. Biol. Phys., (In press).
169. Handelman, G.J., Walter, M.F., Adhikarla, R., Gross, J., Dallal, G.E., Levin, N.W. and Blumberg, J.B. (2001) "Elevated plasma F2-isoprostanes in patients on long-term hemodialysis", Kidney Int. 59, 1960-1966.
170. Ikizler, T.A., Morrow, J.D., Roberts, II, L.J., Evanson, J.A., Becker, B., Hakim, R.M., Shyr, Y. and Himmelfarb, J. (2002) "Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients", Clin. Nephrol. 58, 190-197.
171. Cracowski, J.L., Souvignet, C., Quirin, N., Grosbois, X., Bayle, F., Stanke-Labesque, F., Vialtel, P. and Bessard, G. (2001) "Urinary F2-isoprostanes formation in kidney transplantation", Clin. Transplant. 15, 58-62.
172. Cracowski, J.L., Baguet, J.P., Ormezzano, O., Bessard, J., Stanke-Labesque, F., Bessard, G. and Mallion, J.M. (2003) "Lipid peroxidation is not increased in patients with untreated mild-to-moderate hypertension", Hypertension 41, 286-288.
173. Gopaul, N.K., Manraj, M.D., Hebe, A., Lee Kwai Yan, S., Johnston, A., Carrier, M.J. and Änggård, E.E. (2001) "Oxidative stress could precede endothelial dysfunction and insulin resistance in Indian Mauritians with impaired glucose metabolism", Diabetologia 44, 706-712.
174. Spittle, M.A., Hoenich, N.A., Handelman, G.J., Adhikarla, R., Homel, P. and Levin, N.W. (2001) "Oxidative stress and inflammation in hemodialysis patients", Am. J. Kidney Dis. 38, 1408-1413.
175. Minuz, P., Patrignani, P., Gaino, S., Degan, M., Menapace, L., Tommasoli, R., Seta, F., Capone, M.L., Tacconelli, S., Palatresi, S., Bencini, C., Del Vecchio, C., Mansueto, G., Arosio, E., Santonastaso, C.L., Lechi, A., Morganti, A. and Patrono, C. (2003) "Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease", Circulation 106, 2800-2805.
176. Morrow, J.D. and Roberts, L.J. (1994) "Mass spectrometry of prostanoids: F2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism", Methods Enzymol. 233, 163-174.
177. Morrow, J.D., Zackert, W.E., Yang, J.P., Kurhts, E.H., Callewaert, D., Dworski, R., Kanai, K., Taber, D., Moore, K., Oates, J.A. and Roberts, L.J. (1999) "Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay", Anal. Biochem. 269, 326-331.
178. Nourooz-Zadeh, J., Gopaul, N.K., Barrow, S., Mallet, A.I. and Änggård, E.E. (1995) "Analysis of 172-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure", J. Chromatogr. B. Biomed. Sci. Appl. 667, 199-208.
179. Bessard, J., Cracowski, J.L., Stanke-Labesque, F. and Bessard, G. (2000) "Determination of isoprostaglandin F2alpha type III in human urine by gas chromatography-electronic impact mass spectrometry. Comparison with enzyme immunoassay", J. Chromatogr. B. Biomed. Sci. Appl. 754, 333-343.
180. Walter, M.F., Blumberg, J.B., Dolnikowski, G.G. and Handelman, G.J. (2000) "Streamlined F2-isoprostane analysis in plasma and urine with high-performance chromatography and gas chromatography/mass spectroscopy", Anal. Chem. 280, 73-79.
181. Burke, A., Lawson, J.A., Meagher, E.A., Rokach, J. and FitzGerald, G.A. (2000) "Specific analysis in plasma and urine of 2,3-dinor-5, 6-dihydro-isoprostane F(2alpha)-III, a metabolite of isoprostane F(2alpha)-III and an oxidation product of gamma-linolenic acid", J. Biol. Chem. 275, 2499-2504.
182. Mori, T.A., Croft, K.D., Puddey, I.B. and Beilin, L.J. (2001) "An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry", Anal. Biochem. 268, 117-125.
183. Parker, C.E., Graham, L.B., Nguyen, M.N., Gladen, B.C., Kadiiska, M.B., Barrett, J.C. and Tomer, K.B. (1999) "An improved GC/MS-based procedure for the quantitation of the isoprostane 15-F2t-IsoP in rat plasma", Mol. Biotechnol. 18, 105-118.
184. Adiyaman, M., Lawson, J.A., Khanapure, S.P., FitzGerald, G.A. and Rokach, J. (1998) "Total synthesis of 17,17,18,18-d4-iPF2alpha-VI and quantification of iPF2alpha-VI in human urine by gas chromatography/mass spectrometry", Anal. Biochem. 26, 45-56.
185. Proudfoot, J., Barden, A., Mori, T.A., Burke, V., Croft, K.D., Beilin, L.J. and Puddey, I.B. (1999) "Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry", Anal. Biochem. 272, 209-215.
186. Li, H., Lawson, J.A., Reilly, M., Adiyaman, M., Hwang, S.W, Rokach, J. and FitzGerald, G.A. (1999) "Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urine", Proc. Natl Acad. Sci. 96, 13381-13386.
187. Liang, Y., Wei, P., Duke, R.W., Reaven, P.D., Harman, S.M., Cutler, R. and Heward, C.B. (2003) "Quantification of 8-iso-prostaglandin-F(2alpha) and 2,3-dinor-8-iso-prostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry", Free Radic. Biol. Med. 34, 409-418.
188. Sasaki, D.M., Yuan, Y., Gikas, K., Kanai, K., Taber, D., Morrow, J.D., Roberts, L.J., 2nd and Callewaert, D.M. (2002) "Enzyme immunoassays for 15-F2T isoprostane-M, an urinary biomarker for oxidant stress", Adv. Exp. Med. Biol. 507, 537-541.